Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTARES PHARMA, INC.

(ATRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANTARES PHARMA, INC.
09/08ANTARES PHARMA : to Participate in the H.C. Wainright 23rd Annual Global Investm..
PU
09/08Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Inves..
GL
08/06Antares pharma reports second quarter 2021 financial and operating resultsewi..
AQ
08/05Antares Pharma, Inc. Reaffirms Revenue Guidance for the Full Year 2021
CI
08/05ANTARES PHARMA : Q2 Earnings Snapshot
AQ
08/05ANTARES PHARMA : Earnings Flash (ATRS) ANTARES PHARMA Reports Q2 Revenue $45M, v..
MT
08/05ANTARES PHARMA : Earnings Flash (ATRS) ANTARES PHARMA Posts Q2 EPS $0.03, vs. St..
MT
08/05ANTARES PHARMA : Reports Second Quarter 2021 Financial and Operating Results
AQ
08/05Antares Pharma, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
CI
07/28Antares Pharma to Report Second Quarter 2021 Financial and Operating Results
GL
07/22ANTARES PHARMA : Gets US FDA OK to Start Trial of ATRS-1902 in Acute Adrenal Ins..
MT
07/22ANTARES PHARMA : Announces FDA Acceptance of IND Application for ATRS 1902 For A..
PU
07/22Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for ..
GL
07/22Antares Pharma, Inc Announces FDA Acceptance of IND Application for ATRS-1902..
CI
07/16ANTARES PHARMA : Truist Securities Initiates Coverage on Antares Pharma With Buy..
MT
More most relevant news
All news about ANTARES PHARMA, INC.
09/08ANTARES PHARMA : to Participate in the H.C. Wainright 23rd Annual Global Investm..
PU
09/08Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Inves..
GL
08/18ANTARES PHARMA, INC. : Regulation FD Disclosure (form 8-K)
AQ
08/06Antares pharma reports second quarter 2021 financial and operating resultsewi..
AQ
08/05ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
08/05ANTARES PHARMA, INC. : Results of Operations and Financial Condition, Financial ..
AQ
08/05Antares Pharma, Inc. Reaffirms Revenue Guidance for the Full Year 2021
CI
08/05ANTARES PHARMA : Q2 Earnings Snapshot
AQ
08/05ANTARES PHARMA : Earnings Flash (ATRS) ANTARES PHARMA Reports Q2 Revenue $45M, v..
MT
08/05ANTARES PHARMA : Earnings Flash (ATRS) ANTARES PHARMA Posts Q2 EPS $0.03, vs. St..
MT
More news
News in other languages on ANTARES PHARMA, INC.
06/28Idorsia lance une étude clinique avancée contre l'infarctus
06/28GlobeNewswire/Idorsia initiates the Phase 3 -2-
06/28GlobeNewswire/Idorsia initiates the Phase 3 registration study with selatogre..
More news
Analyst Recommendations on ANTARES PHARMA, INC.
07/16ANTARES PHARMA : Truist Securities Initiates Coverage on Antares Pharma With Buy..
MT
More recommendations
Press releases
09/08ANTARES PHARMA : to Participate in the H.C. Wainright 23rd Annual Global Investm..
PU
09/08Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Inves..
GL
08/18ANTARES PHARMA, INC. : Regulation FD Disclosure (form 8-K)
AQ
08/06Antares pharma reports second quarter 2021 financial and operating resultsewi..
AQ
08/05ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
More press releases
Upcoming event on ANTARES PHARMA, INC.
11/09/21